Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.
NEW YORK Merkley + Partners has eliminated about a dozen positions largely to compensate for the loss of Pfizer’s Lipitor business, the Omnicom Group agency confirmed.
Roughly half the cuts were achieved through layoffs; the rest involved closing out vacant jobs. The cuts equated to roughly 5 percent of the New York agency’s total staff, which is estimated at 260.
Lipitor, with billings of $60-80 million, is still in review, but the New York client eliminated Merkley 2 1/2 months ago in an earlier round [Adweek Online, Sept.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in